Dalargin and liver function during acute hypoxia
Animal research · 2000
- What was studied
- Rats; pressure-chamber model reported as approximately 12,200 m
- Main finding
- The dissertation transcription reports longer survival in severe hypobaric hypoxia at testing times through 168 hours after ordinary intravenous administration and through 336 hours with erythrocyte-carrier delivery. Liver and oxidative-stress markers varied by delivery method and time.
Study data at a glance
- Participants or experimental model
- Rats; pressure-chamber model reported as approximately 12,200 m
- Reported results
- The dissertation transcription reports longer survival in severe hypobaric hypoxia at testing times through 168 hours after ordinary intravenous administration and through 336 hours with erythrocyte-carrier delivery. Liver and oxidative-stress markers varied by delivery method and time.
Study limitations and source details
Study limitations
- Rat experiments do not establish human altitude protection or a seven-day clinical effect.
- Original scan and survival tables remain to be reconciled; numerical survival values are withheld.
- The early time point appears as 0.15 hours in the transcription; it is not safely interpretable as 15 minutes.
Source details
Selected source text and metadata checked; full risk-of-bias review pending.
Selected text reviewed
Sources checked
Citation
V. Yu. Kalinin. Dalargin and liver function during acute hypoxia Candidate dissertation, 2000; web transcription